MCWS
SNOA icon

McKinley Carter Wealth Services’s Sonoma Pharmaceuticals SNOA Stock Holding History

McKinley Carter Wealth Services’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8K Hold
11,193
– – ﹤0.01% 321
2026
Q1 		$23.8K Hold
11,193
– – ﹤0.01% 304
2025
Q4 		$40.7K Buy
+11,193
New +$41.3K ﹤0.01% 319

Other funds holding SNOA

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

McKinley Carter Wealth Services's SNOA Position: Q2 2026 in Review

McKinley Carter Wealth Services held its Sonoma Pharmaceuticals (SNOA) position steady in Q2 2026 at 11,193 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #321.

McKinley Carter Wealth Services first reported a position in SNOA in Q4 2025 and has held it in 3 quarters since. The position peaked at $40.7K in Q4 2025. 14 funds tracked by Wall St. Rank hold SNOA as of Q2 2026.

  • McKinley Carter Wealth Services held 11,193 shares of Sonoma Pharmaceuticals worth $13.8K as of Q2 2026.
  • McKinley Carter Wealth Services left its Sonoma Pharmaceuticals share count unchanged in Q2 2026.
  • Sonoma Pharmaceuticals made up ﹤0.01% of McKinley Carter Wealth Services's portfolio in Q2 2026, its #321 holding.
  • McKinley Carter Wealth Services first reported a position in Sonoma Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • McKinley Carter Wealth Services's Sonoma Pharmaceuticals position peaked at $40.7K in Q4 2025.
  • 14 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q2 2026.

Based on McKinley Carter Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.